点眼薬の世界市場、タイプ別(処方薬 vs 市販薬)、薬物クラス別(抗アレルギー、抗緑内障、抗炎症、抗VEGF、その他)、適応疾患別(眼アレルギー、緑内障、眼感染症、ドライアイ疾患、網膜疾患)、流通チャネル別(病院薬局、小売薬局、オンライン薬局)、地域別、競合予測および機会、2027年Global Eye Drop Market, By Type (Prescription v/s Over-the-Counter), By Drug Class (Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others), By Disease Indication (Eye Allergy, Glaucoma, Eye Infections, Dry Eye Diseases, and Retinal Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region, Competition Forecast and Opportunities, 2027 2021年の世界の点眼薬市場は13530百万米ドルで、予測期間中にCAGR6.46%で成長し、2027年には19758百万米ドルの市場規模に達すると予測されます。この市場は、人口における眼感染症の事例の増加により成長すると... もっと見る
サマリー2021年の世界の点眼薬市場は13530百万米ドルで、予測期間中にCAGR6.46%で成長し、2027年には19758百万米ドルの市場規模に達すると予測されます。この市場は、人口における眼感染症の事例の増加により成長すると予測されています。目の乾燥、充血、目のかゆみ、結膜炎、痛み、緑内障などの眼科疾患の有病率の高さが、今後5年間の世界点眼薬市場の成長をさらに後押しします。スマートフォン、ラップトップ、テレビ、電子機器の過度なスクリーンタイムと普及は、今後5年間の世界点眼薬市場の成長をさらに後押しします。近年、世界各国の政府は医療産業に積極的に投資し、医薬品や治療薬の生産量を増やしています。目薬のような医薬品・治療製品の輸出入の増加は、今後5年間の世界の目薬市場の成長をさらに後押しします。また、同国の消費者は、優れた患者ケアを実現するために、医療サービスに対して支出を行ってきました。また、人口の可処分所得の増加も市場の成長を支えています。製品製造における技術的進歩、製品の容易な流通による物流部門の拡大が、予測期間中の世界点眼薬市場の成長をさらに後押ししています。世界の点眼薬市場は、タイプ、薬物クラス、疾患適応、流通チャネル、競合環境、地域分布によって区分されます。タイプ別に見ると、市場はさらに処方薬と市販薬に区別されます。処方箋型点眼薬は、眼病患者の増加により、今後5年間で最大の売上シェアを占め、市場セグメントを支配すると予想されます。糖尿病のインスタンスが増加し、したがって、目の病気、視力障害をキャッチするの高いリスクは、セグメントの成長を支援する。目の灼熱感や充血などの症状を自己治療する消費者の傾向が高まっているため、市販の目薬が最も速い成長を遂げると予想されます。また、一般的な目のかゆみや長時間のスクリーン使用による乾燥も、今後5年間の世界の目薬市場の成長とともに、このセグメントの成長を後押しします。 ジョンソン&ジョンソン株式会社、ジェネンテック株式会社(ロシュ)、アルコン株式会社、ファイザー株式会社、ボシュ・ヘルス・カンパニーズ株式会社、バイエル株式会社、アラガン株式会社(アッヴィ)、アボット・ラボラトリーズ株式会社、KCファーマ株式会社、アコーン株式会社などが、世界の点眼薬市場の主要市場プレイヤーとして名を連ねています。 本レポートで考慮した年数 歴史的年数:2017年~2020年 基本年:2021年 予測年:2022E 予測年:2023年F~2027年F 本調査の目的 - 2017年から2021年までの世界の点眼薬市場規模の歴史的成長を分析すること。 - 2022E~2027Fの世界における目薬の市場規模および2027Fまでの成長率を予測・推計すること。 - 目薬の世界市場をタイプ、薬物クラス、疾患適応、流通チャネル、競合環境、地域分布に基づいて分類・予測する。 - 世界の点眼薬市場における支配的な地域やセグメントを特定する。 - 世界の点眼薬市場の促進要因と課題を特定する。 - 世界の点眼薬市場における拡張、新製品発表、M&Aなどの競合開発を調査する。 - 世界の点眼薬市場で事業展開している主要企業のプロファイルを特定し、分析する。 - 世界の点眼薬市場で市場参入企業が採用する持続可能な主要戦略を特定する。 TechSci Research社は、この調査のために一次調査と徹底的な二次調査の両方を実施しました。まず、TechSci Researchは世界中の企業のリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査の調査を実施した。インタビューしながら、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった企業も含めることができました。TechSci Research は、世界中のすべての主要企業のメーカー、流通チャネル、存在を分析しました。 TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の目薬市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品や用途の履歴データの分析を通じて外部で検証しました。また、企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。 主な対象読者 - 目薬メーカーおよびサプライヤー - 流通業者およびその他の利害関係者 - 規制当局や政策立案者などの政府機関 - 目薬に関連する組織、フォーラム、アライアンス - 市場調査会社、コンサルティング会社 本調査は、メーカー、サプライヤー、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資戦略を立て、市場機会を活用する上で有用である。 レポートの範囲 本レポートでは、目薬の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。 - 点眼薬市場、タイプ別 o 処方箋薬 o 市販品 - 点眼薬の市場、薬物クラス別 o 抗アレルギー剤 o 緑内障治療薬 o 抗炎症剤 o 抗VEGF o その他 - 点眼薬市場、疾患別適応症別 o 眼アレルギー o 緑内障 o 眼感染症 o ドライアイ o 網膜疾患 - 目薬市場、流通チャネル別 o 病院内薬局 o 小売薬局 o オンライン薬局 - 点眼薬市場、地域別 o 北米 米国 カナダ メキシコ o ヨーロッパ ロシア連邦 イギリス ドイツ フランス スペイン イタリア o アジア太平洋地域 中国 インド 日本 オーストラリア 韓国 インドネシア o 南アメリカ ブラジル アルゼンチン コロンビア o 中東・アフリカ トルコ 南アフリカ共和国 サウジアラビア UAE クウェート 競合他社の状況 企業プロファイル。世界の点眼薬市場に存在する主要企業の詳細な分析。 利用可能なカスタマイズ。 TechSci Researchは与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。 企業情報 - 追加市場プレイヤーの詳細分析およびプロファイリング(最大5社)。 目次1. Product Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Eye Drop Market 5. Voice of Customer 5.1. Brand Awareness 5.2. Factors Contributing to demand for Eye Drops 5.3. Demand, By Drug Class 5.4. Demand, By Disease Indication 5.5. Preference, By Distribution Channel 6. Global Eye Drop Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type (Prescription v/s Over-The-Counter) 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others) 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) 6.2.5. By Region 6.2.6. By Company (2021) 6.3. Product Market Map 7. North America Eye Drop Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Type 7.2.2. By Drug Class 7.2.3. By Disease Indication 7.2.4. By Distribution Channel 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Eye Drop Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Type 7.3.1.2.2. By Drug Class 7.3.1.2.3. By Disease Indication 7.3.1.2.4. By Distribution Channel 7.3.2. Canada Eye Drop Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Type 7.3.2.2.2. By Drug Class 7.3.2.2.3. By Disease Indication 7.3.2.2.4. By Distribution Channel 7.3.3. Mexico Eye Drop Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Type 7.3.3.2.2. By Drug Class 7.3.3.2.3. By Disease Indication 7.3.3.2.4. By Distribution Channel 8. Europe Eye Drop Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Type 8.2.2. By Drug Class 8.2.3. By Disease Indication 8.2.4. By Country 8.3. Europe: Country Analysis 8.3.1. Russia Federation Eye Drop Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Type 8.3.1.2.2. By Drug Class 8.3.1.2.3. By Disease Indication 8.3.1.2.4. By Distribution Channel 8.3.2. United Kingdom Eye Drop Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Type 8.3.2.2.2. By Drug Class 8.3.2.2.3. By Disease Indication 8.3.2.2.4. By Distribution Channel 8.3.3. Germany Eye Drop Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Type 8.3.3.2.2. By Drug Class 8.3.3.2.3. By Disease Indication 8.3.3.2.4. By Distribution Channel 8.3.4. France Eye Drop Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Type 8.3.4.2.2. By Drug Class 8.3.4.2.3. By Disease Indication 8.3.4.2.4. By Distribution Channel 8.3.5. Spain Eye Drop Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Type 8.3.5.2.2. By Drug Class 8.3.5.2.3. By Disease Indication 8.3.5.2.4. By Distribution Channel 8.3.6. Italy Eye Drop Market Outlook 8.3.6.1. Market Size & Forecast 8.3.6.1.1. By Value 8.3.6.2. Market Share & Forecast 8.3.6.2.1. By Type 8.3.6.2.2. By Drug Class 8.3.6.2.3. By Disease Indication 8.3.6.2.4. By Distribution Channel 9. Asia-Pacific Eye Drop Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Type 9.2.2. By Drug Class 9.2.3. By Disease Indication 9.2.4. By Distribution Channel 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Eye Drop Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Type 9.3.1.2.2. By Drug Class 9.3.1.2.3. By Disease Indication 9.3.1.2.4. By Distribution Channel 9.3.2. India Eye Drop Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Type 9.3.2.2.2. By Drug Class 9.3.2.2.3. By Disease Indication 9.3.2.2.4. By Distribution Channel 9.3.3. Japan Eye Drop Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Type 9.3.3.2.2. By Drug Class 9.3.3.2.3. By Disease Indication 9.3.3.2.4. By Distribution Channel 9.3.4. Australia Eye Drop Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Type 9.3.4.2.2. By Drug Class 9.3.4.2.3. By Disease Indication 9.3.4.2.4. By Distribution Channel 9.3.5. South Korea Eye Drop Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Type 9.3.5.2.2. By Drug Class 9.3.5.2.3. By Disease Indication 9.3.5.2.4. By Distribution Channel 9.3.6. Indonesia Eye Drop Market Outlook 9.3.6.1. Market Size & Forecast 9.3.6.1.1. By Value 9.3.6.2. Market Share & Forecast 9.3.6.2.1. By Type 9.3.6.2.2. By Drug Class 9.3.6.2.3. By Disease Indication 9.3.6.2.4. By Distribution Channel 10. South America Eye Drop Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Type 10.2.2. By Drug Class 10.2.3. By Disease Indication 10.2.4. By Distribution Channel 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Eye Drop Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Type 10.3.1.2.2. By Drug Class 10.3.1.2.3. By Disease Indication 10.3.1.2.4. By Distribution Channel 10.3.2. Argentina Eye Drop Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Type 10.3.2.2.2. By Drug Class 10.3.2.2.3. By Disease Indication 10.3.2.2.4. By Distribution Channel 10.3.3. Colombia Eye Drop Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Type 10.3.3.2.2. By Drug Class 10.3.3.2.3. By Disease Indication 10.3.3.2.4. By Distribution Channel 11. Middle East and Africa Eye Drop Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Type 11.2.2. By Drug Class 11.2.3. By Disease Indication 11.2.4. By Distribution Channel 11.2.5. By Country 11.3. MEA: Country Analysis 11.3.1. Turkey Eye Drop Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Type 11.3.1.2.2. By Drug Class 11.3.1.2.3. By Disease Indication 11.3.1.2.4. By Distribution Channel 11.3.2. South Africa Eye Drop Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Type 11.3.2.2.2. By Drug Class 11.3.2.2.3. By Disease Indication 11.3.2.2.4. By Distribution Channel 11.3.3. Saudi Arabia Eye Drop Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Type 11.3.3.2.2. By Drug Class 11.3.3.2.3. By Disease Indication 11.3.3.2.4. By Distribution Channel 11.3.4. UAE Eye Drop Market Outlook 11.3.4.1. Market Size & Forecast 11.3.4.1.1. By Value 11.3.4.2. Market Share & Forecast 11.3.4.2.1. By Type 11.3.4.2.2. By Drug Class 11.3.4.2.3. By Disease Indication 11.3.4.2.4. By Distribution Channel 11.3.5. Kuwait Eye Drop Market Outlook 11.3.5.1. Market Size & Forecast 11.3.5.1.1. By Value 11.3.5.2. Market Share & Forecast 11.3.5.2.1. By Type 11.3.5.2.2. By Drug Class 11.3.5.2.3. By Disease Indication 11.3.5.2.4. By Distribution Channel 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Johnson & Johnson Inc. 14.2. Genentech, Inc. (Roche) 14.3. Alcon Inc. 14.4. Pfizer, Inc. 14.5. Bausch Health Companies, Inc. 14.6. Bayer Corporation 14.7. Allergan, Inc. (AbbVie) 14.8. Abbott Laboratories Inc. 14.9. KC Pharmaceuticals, Inc. 14.10. Akorn, Inc. 15. Strategic Recommendations 16. About Us & Disclaimer
SummaryGlobal eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027. The market is anticipated to grow on account of increasing instances of eye infection in the population. Higher prevalence of eye diseases like eye dryness, redness, itching in the eyes, conjunctivitis, soreness, glaucoma, etc. further drive the growth of the global eye drop market in the upcoming five years. Excessive screen time and penetration of smart phones, laptops, television, and electronics further supports the growth of the global eye drop market in the next five years. The governments around the world are actively investing in the healthcare industry and increasing the production of the pharmaceuticals and therapeutics products in the recent years. Growing imports & exports of the pharmaceutical & therapeutics products like eye drops further aid the growth of the global eye drop market in the future five years. Also, the consumers in the country have been spending over healthcare services to attain excellent patient care. Rising disposable income of the population also sustains the market growth. Technological advancement in product manufacturing, expanding logistics sector with easy distribution of the products further aids the growth of the global eye drop market in the forecast period. Table of Contents1. Product Overview2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Eye Drop Market 5. Voice of Customer 5.1. Brand Awareness 5.2. Factors Contributing to demand for Eye Drops 5.3. Demand, By Drug Class 5.4. Demand, By Disease Indication 5.5. Preference, By Distribution Channel 6. Global Eye Drop Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type (Prescription v/s Over-The-Counter) 6.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) 6.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others) 6.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) 6.2.5. By Region 6.2.6. By Company (2021) 6.3. Product Market Map 7. North America Eye Drop Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Type 7.2.2. By Drug Class 7.2.3. By Disease Indication 7.2.4. By Distribution Channel 7.2.5. By Country 7.3. North America: Country Analysis 7.3.1. United States Eye Drop Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Type 7.3.1.2.2. By Drug Class 7.3.1.2.3. By Disease Indication 7.3.1.2.4. By Distribution Channel 7.3.2. Canada Eye Drop Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Type 7.3.2.2.2. By Drug Class 7.3.2.2.3. By Disease Indication 7.3.2.2.4. By Distribution Channel 7.3.3. Mexico Eye Drop Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Type 7.3.3.2.2. By Drug Class 7.3.3.2.3. By Disease Indication 7.3.3.2.4. By Distribution Channel 8. Europe Eye Drop Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Type 8.2.2. By Drug Class 8.2.3. By Disease Indication 8.2.4. By Country 8.3. Europe: Country Analysis 8.3.1. Russia Federation Eye Drop Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Type 8.3.1.2.2. By Drug Class 8.3.1.2.3. By Disease Indication 8.3.1.2.4. By Distribution Channel 8.3.2. United Kingdom Eye Drop Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Type 8.3.2.2.2. By Drug Class 8.3.2.2.3. By Disease Indication 8.3.2.2.4. By Distribution Channel 8.3.3. Germany Eye Drop Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Type 8.3.3.2.2. By Drug Class 8.3.3.2.3. By Disease Indication 8.3.3.2.4. By Distribution Channel 8.3.4. France Eye Drop Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Type 8.3.4.2.2. By Drug Class 8.3.4.2.3. By Disease Indication 8.3.4.2.4. By Distribution Channel 8.3.5. Spain Eye Drop Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Type 8.3.5.2.2. By Drug Class 8.3.5.2.3. By Disease Indication 8.3.5.2.4. By Distribution Channel 8.3.6. Italy Eye Drop Market Outlook 8.3.6.1. Market Size & Forecast 8.3.6.1.1. By Value 8.3.6.2. Market Share & Forecast 8.3.6.2.1. By Type 8.3.6.2.2. By Drug Class 8.3.6.2.3. By Disease Indication 8.3.6.2.4. By Distribution Channel 9. Asia-Pacific Eye Drop Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Type 9.2.2. By Drug Class 9.2.3. By Disease Indication 9.2.4. By Distribution Channel 9.2.5. By Country 9.3. Asia-Pacific: Country Analysis 9.3.1. China Eye Drop Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Type 9.3.1.2.2. By Drug Class 9.3.1.2.3. By Disease Indication 9.3.1.2.4. By Distribution Channel 9.3.2. India Eye Drop Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Type 9.3.2.2.2. By Drug Class 9.3.2.2.3. By Disease Indication 9.3.2.2.4. By Distribution Channel 9.3.3. Japan Eye Drop Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Type 9.3.3.2.2. By Drug Class 9.3.3.2.3. By Disease Indication 9.3.3.2.4. By Distribution Channel 9.3.4. Australia Eye Drop Market Outlook 9.3.4.1. Market Size & Forecast 9.3.4.1.1. By Value 9.3.4.2. Market Share & Forecast 9.3.4.2.1. By Type 9.3.4.2.2. By Drug Class 9.3.4.2.3. By Disease Indication 9.3.4.2.4. By Distribution Channel 9.3.5. South Korea Eye Drop Market Outlook 9.3.5.1. Market Size & Forecast 9.3.5.1.1. By Value 9.3.5.2. Market Share & Forecast 9.3.5.2.1. By Type 9.3.5.2.2. By Drug Class 9.3.5.2.3. By Disease Indication 9.3.5.2.4. By Distribution Channel 9.3.6. Indonesia Eye Drop Market Outlook 9.3.6.1. Market Size & Forecast 9.3.6.1.1. By Value 9.3.6.2. Market Share & Forecast 9.3.6.2.1. By Type 9.3.6.2.2. By Drug Class 9.3.6.2.3. By Disease Indication 9.3.6.2.4. By Distribution Channel 10. South America Eye Drop Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Type 10.2.2. By Drug Class 10.2.3. By Disease Indication 10.2.4. By Distribution Channel 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Eye Drop Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Type 10.3.1.2.2. By Drug Class 10.3.1.2.3. By Disease Indication 10.3.1.2.4. By Distribution Channel 10.3.2. Argentina Eye Drop Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Type 10.3.2.2.2. By Drug Class 10.3.2.2.3. By Disease Indication 10.3.2.2.4. By Distribution Channel 10.3.3. Colombia Eye Drop Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Type 10.3.3.2.2. By Drug Class 10.3.3.2.3. By Disease Indication 10.3.3.2.4. By Distribution Channel 11. Middle East and Africa Eye Drop Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Type 11.2.2. By Drug Class 11.2.3. By Disease Indication 11.2.4. By Distribution Channel 11.2.5. By Country 11.3. MEA: Country Analysis 11.3.1. Turkey Eye Drop Market Outlook 11.3.1.1. Market Size & Forecast 11.3.1.1.1. By Value 11.3.1.2. Market Share & Forecast 11.3.1.2.1. By Type 11.3.1.2.2. By Drug Class 11.3.1.2.3. By Disease Indication 11.3.1.2.4. By Distribution Channel 11.3.2. South Africa Eye Drop Market Outlook 11.3.2.1. Market Size & Forecast 11.3.2.1.1. By Value 11.3.2.2. Market Share & Forecast 11.3.2.2.1. By Type 11.3.2.2.2. By Drug Class 11.3.2.2.3. By Disease Indication 11.3.2.2.4. By Distribution Channel 11.3.3. Saudi Arabia Eye Drop Market Outlook 11.3.3.1. Market Size & Forecast 11.3.3.1.1. By Value 11.3.3.2. Market Share & Forecast 11.3.3.2.1. By Type 11.3.3.2.2. By Drug Class 11.3.3.2.3. By Disease Indication 11.3.3.2.4. By Distribution Channel 11.3.4. UAE Eye Drop Market Outlook 11.3.4.1. Market Size & Forecast 11.3.4.1.1. By Value 11.3.4.2. Market Share & Forecast 11.3.4.2.1. By Type 11.3.4.2.2. By Drug Class 11.3.4.2.3. By Disease Indication 11.3.4.2.4. By Distribution Channel 11.3.5. Kuwait Eye Drop Market Outlook 11.3.5.1. Market Size & Forecast 11.3.5.1.1. By Value 11.3.5.2. Market Share & Forecast 11.3.5.2.1. By Type 11.3.5.2.2. By Drug Class 11.3.5.2.3. By Disease Indication 11.3.5.2.4. By Distribution Channel 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Johnson & Johnson Inc. 14.2. Genentech, Inc. (Roche) 14.3. Alcon Inc. 14.4. Pfizer, Inc. 14.5. Bausch Health Companies, Inc. 14.6. Bayer Corporation 14.7. Allergan, Inc. (AbbVie) 14.8. Abbott Laboratories Inc. 14.9. KC Pharmaceuticals, Inc. 14.10. Akorn, Inc. 15. Strategic Recommendations 16. About Us & Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(通信回線)の最新刊レポート
TechSci Research 社の最新刊レポート
本レポートと同じKEY WORD(antiinflammatory)の最新刊レポート
よくあるご質問TechSci Research社はどのような調査会社ですか?テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/06 10:26 144.24 円 160.68 円 192.83 円 |